$PFE Company News Large-caps can boost your port
Post# of 89114
Posted On: 11/29/2013 3:15:09 PM
$PFE Company News
Large-caps can boost your portfolio at year-end 2:58 p.m. Nov. 22, 2013 - Mark Hulbert
Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
Where's the market oopmh? Cisco and a turnaround on Exxon Mobil 8:45 a.m. Nov. 13, 2013 - blogs.marketwatch.com
Everything you need to know about buying Bitcoins 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Pfizer's Rapamune doesn't meet primary endpoint 8:51 a.m. Nov. 8, 2013 - MarketWatch.com
Is this March 2000 all over again? 3:07 p.m. Nov. 7, 2013 - Mark Hulbert
Newscast: The Dow and S&P 500 set new record highs 6:31 p.m. Oct. 29, 2013 - MarketWatch
Energy stocks gain; BP shares rally on earnings 5:12 p.m. Oct. 29, 2013 - Claudia Assis
S&P 500, Dow industrials close at record highs 4:41 p.m. Oct. 29, 2013 - Victor Reklaitis
Newscast: Wall Street heads higher and sets record 4:33 p.m. Oct. 29, 2013 - MarketWatch
U.S. stocks open higher; Pfizer rises 1% 9:36 a.m. Oct. 29, 2013 - Victor Reklaitis
Stock futures up slightly ahead of Fed meeting 9:04 a.m. Oct. 29, 2013 - Sara Sjolin
Pfizer profit falls, adjusts full-year views 7:24 a.m. Oct. 29, 2013 - MarketWatch.com
Pfizer net falls, adjusts full-year earnings range 7:18 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 revenue down 2% to $12.64 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 profit falls 19% to $2.59 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 EPS falls to $0.39; adj. EPS up to $0.58 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Cat's warning sign, a Michael Kors pop and the surf pounds Portugal 6:11 a.m. Oct. 29, 2013 - blogs.marketwatch.com
Apple, LinkedIn, Pfizer, Michael Kors: hot stocks 5:30 a.m. Oct. 29, 2013 - Ben Eisen
Buy Recommendation Reiterated For Pfizer Inc 9:00 a.m. Today - TheStreet.com
GlaxoSmithKline: What's The Next Growth Driver? 2:38 p.m. Nov. 26, 2013 - Seeking Alpha
Stock Market News for November 26, 2013 - Market News 10:06 a.m. Nov. 26, 2013 - Zacks.com
Pain Therapeutics: Very Substantial Risk-Adjusted Upside Vs. Downside 9:45 a.m. Nov. 26, 2013 - Seeking Alpha
Can Pfizer Continue to Outperform? 5:29 p.m. Nov. 25, 2013 - Wall St. Cheat Sheet
Most popular hedge fund shorts according to Goldman monitor 4:03 p.m. Nov. 25, 2013 - Seeking Alpha
Pfizer: 3 Different Insiders Have Sold Shares During The Last 30 Days 3:54 p.m. Nov. 25, 2013 - Seeking Alpha
Glaxo Shares Rise on Tivicay News - Analyst Blog 2:13 p.m. Nov. 25, 2013 - Zacks.com
Rexahn's Akt-1 Inhibitor To Begin Phase II Trials For Kidney Treatment 1:47 p.m. Nov. 25, 2013 - Seeking Alpha
Pfizer Subsidiary to Take Over Local Affiliate Wyeth in India 1:23 p.m. Nov. 25, 2013 - Wall St. Cheat Sheet
$112 Billion Fund Down On Stocks: Except These 12:05 p.m. Nov. 25, 2013 - Seeking Alpha
Pfizer to Wed Indian Operations and Wyeth’s India Unit 11:44 a.m. Nov. 25, 2013 - Wall St. Cheat Sheet
Stock Market News for November 25, 2013 - Market News 10:06 a.m. Nov. 25, 2013 - Zacks.com
Pfizer's Indian unit to take full control of Wyeth 4:03 a.m. Nov. 24, 2013 - Seeking Alpha
Pfizer Feels the Heat From Novartis 4:14 p.m. Nov. 22, 2013 - Wall St. Cheat Sheet
Neurotrope: Intriguing Play On Alzheimer's 3:58 p.m. Nov. 22, 2013 - Seeking Alpha
Novartis ambushes Pfizer with breast cancer treatment 3:06 p.m. Nov. 22, 2013 - Seeking Alpha
4 Biotech Stocks Making Big Moves 12:47 p.m. Nov. 22, 2013 - Wall St. Cheat Sheet
Two Small-Cap Biotechs to Watch 12:00 p.m. Nov. 22, 2013 - RealMoney.com
Wall Street Breakfast: Must-Know News 6:33 a.m. Nov. 22, 2013 - Seeking Alpha
New Products, Positive Clinical Trial Results, FDA Submissions and Stock Price Updates - Research Report on Pfizer, Cubist, Zoetis, Edwards Lifesciences, and C.R. Bard 8:00 a.m. Nov. 28, 2013 - PR Newswire
FDA Approvals, New Appointments, and Official Statements - Research Report on Pfizer, Aetna, Lilly, GSK, and Sanofi 8:00 a.m. Nov. 27, 2013 - PR Newswire
Just in Time for Peak Travel Season, Introducing New Robitussin(R) DM Max Liquid-Filled Capsules 9:00 a.m. Nov. 25, 2013 - BusinessWire
Upcoming Conference Schedules, Orphan Drug Designations and Stock Price Updates - Research Report on Pfizer, ICU Medical, CONMED, Gentium, and Repros Therapeutics 8:00 a.m. Nov. 25, 2013 - PR Newswire
Tivicay® (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV 9:00 a.m. Nov. 22, 2013 - PR Newswire
Pfizer's XALKORI(R) Granted Regular FDA Approval 11:00 a.m. Nov. 21, 2013 - BusinessWire
Pfizer and GSK to Initiate Study of Novel Combination Therapy in Patients with Melanoma 8:00 a.m. Nov. 21, 2013 - BusinessWire
FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics 8:00 a.m. Nov. 21, 2013 - PR Newswire
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer 7:00 a.m. Nov. 21, 2013 - GlobeNewswire
Notes Redemption, Upcoming Presentations, and Manufacturing Investments - Research Report on Pfizer, Baxter, Lilly, UnitedHealth Group, and Align Technology 8:00 a.m. Nov. 19, 2013 - PR Newswire
Pfizer Announces FDA Approval of Supplemental Application to Expand XELJANZ(R) (tofacitinib citrate) Labeling to Include Additional Patient-Reported Outcomes Data for Adults with Moderately to Severely Active Rheumatoid Arthritis 4:47 p.m. Nov. 18, 2013 - BusinessWire
Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 6:21 p.m. Nov. 14, 2013 - PR Newswire
Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014 8:30 a.m. Nov. 14, 2013 - BusinessWire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Athersys Recognized Among Fastest Growing Companies in North America on Deloitte's 2013 Technology Fast 500(TM) 2:00 p.m. Nov. 13, 2013 - GlobeNewswire
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE(R) (sirolimus) In Renal Transplant Recipients 8:00 a.m. Nov. 8, 2013 - BusinessWire
The Global Revolution in Biotechnology and the Impact of Regenerative Medicine 9:53 a.m. Nov. 7, 2013 - ACCESSWIRE
GlycoMimetics to Present Five Abstracts at 2013 American Society of Hematology Annual Meeting 9:11 a.m. Nov. 7, 2013 - BusinessWire
FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech 8:00 a.m. Nov. 7, 2013 - PR Newswire
Large-caps can boost your portfolio at year-end 2:58 p.m. Nov. 22, 2013 - Mark Hulbert
Stock market live blog: S&P 500 record, Twitter options, China ETFs (Recap) 11:39 a.m. Nov. 18, 2013 - blogs.marketwatch.com
The best stock sector for your money now 6:01 a.m. Nov. 15, 2013 - Howard Gold
Where's the market oopmh? Cisco and a turnaround on Exxon Mobil 8:45 a.m. Nov. 13, 2013 - blogs.marketwatch.com
Everything you need to know about buying Bitcoins 3:22 p.m. Nov. 12, 2013 - blogs.marketwatch.com
Pfizer's Rapamune doesn't meet primary endpoint 8:51 a.m. Nov. 8, 2013 - MarketWatch.com
Is this March 2000 all over again? 3:07 p.m. Nov. 7, 2013 - Mark Hulbert
Newscast: The Dow and S&P 500 set new record highs 6:31 p.m. Oct. 29, 2013 - MarketWatch
Energy stocks gain; BP shares rally on earnings 5:12 p.m. Oct. 29, 2013 - Claudia Assis
S&P 500, Dow industrials close at record highs 4:41 p.m. Oct. 29, 2013 - Victor Reklaitis
Newscast: Wall Street heads higher and sets record 4:33 p.m. Oct. 29, 2013 - MarketWatch
U.S. stocks open higher; Pfizer rises 1% 9:36 a.m. Oct. 29, 2013 - Victor Reklaitis
Stock futures up slightly ahead of Fed meeting 9:04 a.m. Oct. 29, 2013 - Sara Sjolin
Pfizer profit falls, adjusts full-year views 7:24 a.m. Oct. 29, 2013 - MarketWatch.com
Pfizer net falls, adjusts full-year earnings range 7:18 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 revenue down 2% to $12.64 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 profit falls 19% to $2.59 billion 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Pfizer Q3 EPS falls to $0.39; adj. EPS up to $0.58 7:04 a.m. Oct. 29, 2013 - Saumya Vaishampayan
Cat's warning sign, a Michael Kors pop and the surf pounds Portugal 6:11 a.m. Oct. 29, 2013 - blogs.marketwatch.com
Apple, LinkedIn, Pfizer, Michael Kors: hot stocks 5:30 a.m. Oct. 29, 2013 - Ben Eisen
Buy Recommendation Reiterated For Pfizer Inc 9:00 a.m. Today - TheStreet.com
GlaxoSmithKline: What's The Next Growth Driver? 2:38 p.m. Nov. 26, 2013 - Seeking Alpha
Stock Market News for November 26, 2013 - Market News 10:06 a.m. Nov. 26, 2013 - Zacks.com
Pain Therapeutics: Very Substantial Risk-Adjusted Upside Vs. Downside 9:45 a.m. Nov. 26, 2013 - Seeking Alpha
Can Pfizer Continue to Outperform? 5:29 p.m. Nov. 25, 2013 - Wall St. Cheat Sheet
Most popular hedge fund shorts according to Goldman monitor 4:03 p.m. Nov. 25, 2013 - Seeking Alpha
Pfizer: 3 Different Insiders Have Sold Shares During The Last 30 Days 3:54 p.m. Nov. 25, 2013 - Seeking Alpha
Glaxo Shares Rise on Tivicay News - Analyst Blog 2:13 p.m. Nov. 25, 2013 - Zacks.com
Rexahn's Akt-1 Inhibitor To Begin Phase II Trials For Kidney Treatment 1:47 p.m. Nov. 25, 2013 - Seeking Alpha
Pfizer Subsidiary to Take Over Local Affiliate Wyeth in India 1:23 p.m. Nov. 25, 2013 - Wall St. Cheat Sheet
$112 Billion Fund Down On Stocks: Except These 12:05 p.m. Nov. 25, 2013 - Seeking Alpha
Pfizer to Wed Indian Operations and Wyeth’s India Unit 11:44 a.m. Nov. 25, 2013 - Wall St. Cheat Sheet
Stock Market News for November 25, 2013 - Market News 10:06 a.m. Nov. 25, 2013 - Zacks.com
Pfizer's Indian unit to take full control of Wyeth 4:03 a.m. Nov. 24, 2013 - Seeking Alpha
Pfizer Feels the Heat From Novartis 4:14 p.m. Nov. 22, 2013 - Wall St. Cheat Sheet
Neurotrope: Intriguing Play On Alzheimer's 3:58 p.m. Nov. 22, 2013 - Seeking Alpha
Novartis ambushes Pfizer with breast cancer treatment 3:06 p.m. Nov. 22, 2013 - Seeking Alpha
4 Biotech Stocks Making Big Moves 12:47 p.m. Nov. 22, 2013 - Wall St. Cheat Sheet
Two Small-Cap Biotechs to Watch 12:00 p.m. Nov. 22, 2013 - RealMoney.com
Wall Street Breakfast: Must-Know News 6:33 a.m. Nov. 22, 2013 - Seeking Alpha
New Products, Positive Clinical Trial Results, FDA Submissions and Stock Price Updates - Research Report on Pfizer, Cubist, Zoetis, Edwards Lifesciences, and C.R. Bard 8:00 a.m. Nov. 28, 2013 - PR Newswire
FDA Approvals, New Appointments, and Official Statements - Research Report on Pfizer, Aetna, Lilly, GSK, and Sanofi 8:00 a.m. Nov. 27, 2013 - PR Newswire
Just in Time for Peak Travel Season, Introducing New Robitussin(R) DM Max Liquid-Filled Capsules 9:00 a.m. Nov. 25, 2013 - BusinessWire
Upcoming Conference Schedules, Orphan Drug Designations and Stock Price Updates - Research Report on Pfizer, ICU Medical, CONMED, Gentium, and Repros Therapeutics 8:00 a.m. Nov. 25, 2013 - PR Newswire
Tivicay® (dolutegravir) receives positive CHMP opinion in Europe for the treatment of HIV 9:00 a.m. Nov. 22, 2013 - PR Newswire
Pfizer's XALKORI(R) Granted Regular FDA Approval 11:00 a.m. Nov. 21, 2013 - BusinessWire
Pfizer and GSK to Initiate Study of Novel Combination Therapy in Patients with Melanoma 8:00 a.m. Nov. 21, 2013 - BusinessWire
FDA Approvals, Stock Price Movements, and Study Results - Research Report on Pfizer, Celgene, Merck, Quest Diagnostics, and Pharmacyclics 8:00 a.m. Nov. 21, 2013 - PR Newswire
Lithera Announces Appointment of Dermatology and Aesthetics Authority Dr. Lincoln Krochmal as Chief Medical Officer 7:00 a.m. Nov. 21, 2013 - GlobeNewswire
Notes Redemption, Upcoming Presentations, and Manufacturing Investments - Research Report on Pfizer, Baxter, Lilly, UnitedHealth Group, and Align Technology 8:00 a.m. Nov. 19, 2013 - PR Newswire
Pfizer Announces FDA Approval of Supplemental Application to Expand XELJANZ(R) (tofacitinib citrate) Labeling to Include Additional Patient-Reported Outcomes Data for Adults with Moderately to Severely Active Rheumatoid Arthritis 4:47 p.m. Nov. 18, 2013 - BusinessWire
Today's Research: Pfizer Inc., Merck & Co. Inc., AbbVie Inc., and Zogenix Inc. 6:21 p.m. Nov. 14, 2013 - PR Newswire
Pfizer Subsidiary, Wyeth LLC, To Redeem 5.500% Notes Due February 1, 2014 8:30 a.m. Nov. 14, 2013 - BusinessWire
Acquisitions, Clinical Trial Results and Stock Price Movements - Research Report on ViroPharma, Pfizer, Alkermes, Tenet, and ResMed 8:00 a.m. Nov. 14, 2013 - PR Newswire
Athersys Recognized Among Fastest Growing Companies in North America on Deloitte's 2013 Technology Fast 500(TM) 2:00 p.m. Nov. 13, 2013 - GlobeNewswire
Critical Alerts For Micron Technology, Sarepta Therapeutics, Alliance Fiber Optic Products, Pfizer, and KB Home Released By InvestorsObserver 9:31 a.m. Nov. 11, 2013 - PR Newswire
Pfizer Announces Top-Line Results Of Phase 3B/4 Study Of RAPAMUNE(R) (sirolimus) In Renal Transplant Recipients 8:00 a.m. Nov. 8, 2013 - BusinessWire
The Global Revolution in Biotechnology and the Impact of Regenerative Medicine 9:53 a.m. Nov. 7, 2013 - ACCESSWIRE
GlycoMimetics to Present Five Abstracts at 2013 American Society of Hematology Annual Meeting 9:11 a.m. Nov. 7, 2013 - BusinessWire
FDA Approvals, Successful Product Launches, Upcoming Earnings Schedules and Quarterly Financial Results - Research Report on Pfizer, Mettler-Toledo, Arena, Wright Medical, and Ophthotech 8:00 a.m. Nov. 7, 2013 - PR Newswire
(0)
(0)Scroll down for more posts ▼